Peer-to-peer social media contraception education for 15–19 year olds in Guadeloupe and La Réunion

Assessing the faiSAbility of a Peer-to-peer Contraceptive Education Program on Social Networks Aimed at 15- to 19-year-old High School Students in GuAdeloupe and La RéunIon: a Before-after SAPLAI Pilot Study

Observational Centre Hospitalier Universitaire de la Réunion · NCT06943209

This project will try using trained high-school peer influencers to share contraception information on social networks with students aged 15–19 in Guadeloupe and La Réunion.

Quick facts

Study typeObservational
Enrollment120 (estimated)
Ages15 Years to 19 Years
SexAll
SponsorCentre Hospitalier Universitaire de la Réunion Academic / other
Locations2 sites (Port-Louis, Guadeloupe and 1 other locations)
Trial IDNCT06943209 on ClinicalTrials.gov

What this trial studies

This is a before-and-after observational program that trains selected vocational high-school students as peer influencers to create and post contraception education on social networks. All participating students will complete questionnaires on sexual health knowledge, attitudes, and practices, and some will join focus groups to discuss the value of peer educators. The program will measure feasibility, adoption, acceptability, fidelity, and exploratory effects on knowledge and attitudes. Activities take place in selected vocational high schools with parental consent required for minors.

Who should consider this trial

Good fit: Ideal candidates are 15–19-year-old vocational high school students living in La Réunion or Guadeloupe whose school agrees to participate and who provide consent (peer influencers should have basic digital skills and a video-capable smartphone).

Not a fit: Young people outside the 15–19 age range, those not enrolled in participating schools, those already involved in similar programs, or students without parental consent are unlikely to benefit from this program.

Why it matters

Potential benefit: If successful, the program could increase young people's access to accurate contraception information through trusted peers and improve knowledge and attitudes about sexual health.

How similar studies have performed: Similar peer-led and social-media sexual health programs have produced modest improvements in knowledge and attitudes in other settings, but evidence for durable behavior change is mixed.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* HIGH SCHOOL STUDENTS
* Young men and women aged between 15 and 19
* Living in La Réunion or Guadeloupe
* Enrolled in one of the selected vocational high schools and whose school principal agrees to take part in the program
* Who have agreed to take part in the study
* Who have received written consent from a parent or guardian.

PEER INFLUENCERS

* Young men and women aged between 15 and 19
* Living in La Réunion or Guadeloupe
* Enrolled in one of the selected vocational high schools and whose school principal agrees to participate in the program
* Selected in seconde class and admitted to première class
* Have been chosen as a peer
* Have a sense of self-efficacy in the use of computers
* Have good communication skills
* Possession of a video-capable smartphone
* Having agreed to take part in the study
* Written consent from a parent or guardian

Exclusion Criteria:

\- Involved in other similar programs

Where this trial is running

Port-Louis, Guadeloupe and 1 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Contraception Behaviorinfluencerspeer educatorsstudentssexual health
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.